Methanolic Extract of Rhizoma Coptidis Inhibits the Early Viral Entry Steps of Hepatitis C Virus Infection

Coptidis rhizoma and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity

(2018) Fan-Cheng Meng et al.   Chinese Medicine

Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state

(2017) Byeong-Hoon Lee et al.   JOURNAL OF MICROBIOLOGY

Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry

(2016) Chueh-Yao Chung et al.   ANTIVIRAL RESEARCH

Highly bioavailable silibinin nanoparticles inhibit HCV infection

(2016) Ching-Hsuan Liu et al.   GUT

Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection

(2016) Zaili Yang et al.   JOURNAL OF VIROLOGY

(4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus Entry

(2016) Chueh-Yao Chung et al.   Scientific Reports

Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry

(2015) Wen-Chan Hsu et al.   ANTIVIRAL RESEARCH

Drug interactions with new hepatitis C oral drugs

(2015) Vincent Soriano et al.   Expert Opinion on Drug Metabolism & Toxicology

Hepatitis C virus treatment in the real world: optimising treatment and access to therapies: Table 1

(2015) Fabien Zoulim et al.   GUT

Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry

(2015) Liang-Tzung Lin et al.   JOURNAL OF HEPATOLOGY

Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus

(2015) Takasuke Fukuhara et al.   TRENDS IN MICROBIOLOGY

Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C

(2014) Fei Xiao et al.   GUT

Antiviral treatment of hepatitis C

(2014) E. R. Feeney et al.   BMJ-British Medical Journal

Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry

(2013) Liang-Tzung Lin et al.   BMC MICROBIOLOGY

Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking

(2013) Julie Blaising et al.   CELLULAR MICROBIOLOGY

Characterization of protoberberine alkaloids in Coptidis Rhizoma (Huanglian) by HPLC with ESI-MS/MS

(2013) Lingling Ren et al.   JOURNAL OF SEPARATION SCIENCE

A Plant-Derived Flavonoid Inhibits Entry of All HCV Genotypes Into Human Hepatocytes

(2012) Sibylle Haid et al.   GASTROENTEROLOGY

Hydrolyzable Tannins (Chebulagic Acid and Punicalagin) Target Viral Glycoprotein-Glycosaminoglycan Interactions To Inhibit Herpes Simplex Virus 1 Entry and Cell-to-Cell Spread

(2011) L.-T. Lin et al.   JOURNAL OF VIROLOGY

Anti-herpes simplex virus effects of berberine from Coptidis rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San

(2010) Lengsu William Chin et al.   ARCHIVES OF VIROLOGY

Multiple effects of silymarin on the hepatitis C virus lifecycle

(2010) Jessica Wagoner et al.   HEPATOLOGY

Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted

(2008) Elizabeth C. Verna et al.   Clinics in Liver Disease

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs

(2008) Judith M. Gottwein et al.   HEPATOLOGY

In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex

(2007) Hye-Young Kim et al.   JOURNAL OF CLINICAL VIROLOGY